The lethal obese condition accelerates the incidence of type 2 diabetes (T2D) via increased adipokine, proinflammatory cytokines synthesis, and impaired insulin signaling and increased insulin resistance. This evidence concerns the gene INS and type 2 diabetes mellitus.